Response

  • Head and neck cancer clinical trial reports high complete pathological response rate

    BioVex announces that the data from its completed phase one/two clinical study of OncoVexGM-CSF for the first line treatment of head and neck cancer is being published in Clinical Cancer Research. The previously announced top line results report…

    Response | 17 August 2010

  • Genetic Technologies Becomes Distributor for Response Genetics in Asia

    Genetic Technologies has executed an Exclusive Test Distribution and Services Agreement with Response Genetics, under which the former will become the exclusive distributor in Australia, Indonesia, Malaysia, the Philippines, Singapore and Thailand. …

    Response | 07 January 2010

  • Growth Response

    The mass expansion of the middle class in countries like India and China appears to be fuelling growth in the pharmaceuticals industry. According to Nick Roelofs, VP and GM of the Life Sciences Solutions unit, Agilent, several million people in In…

    Response | 01 August 2009

  • Watson Receives FDA Response on Cancer Drug

    Watson Pharmaceuticals has received a Complete Response Letter from the US Food and Drug Administration (FDA) on its New Drug Application (NDA) for Trelstar 22.5 mg (triptorelin pamoate for injectable suspension), a 24-week formulation for the pallia…

    Response | 16 July 2009

  • High-dose influenza vaccine shows increased immune response among adults

    Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced that an investigational high-dose influenza vaccine demonstrated increased immune responses among adults 65 years of age and older compared with the standard influenza vaccine. …

    Response | 04 November 2008

  • Study: Tattooing Improves Response To DNA Vaccine

    A tattoo can be more than just a fashion statement – it has potential medical value, according to an article published in the online open access journal, Genetic Vaccines and Therapy. Martin Müller and his team at the Deutsches Krebsforschungs…

    Response | 03 March 2008

  • WHO, Stop TB Partnership Release Two-Year Response Plan

    Hundreds of thousands of cases of drug-resistant tuberculosis (TB) can be prevented and as many as 134,000 lives saved through the implementation of a two-year response plan, published/launched today by the World Health Organization (WHO) and the Sto…

    Response | 29 June 2007